Speaker Profile
Biography
Dr. George Coukos, a leading figure in tumor immunology, serves as the director of the Lausanne Branch of the Ludwig Institute for Cancer Research and the Department of Oncology at the University of Lausanne in Switzerland. His pioneering work presently focuses on developing precision immunotherapy in cancer treatment, particularly in Tcell therapies. Notably, he's been instrumental in developing personalized immunotherapies, including an autologous dendritic cell vaccine and adoptive Tcell therapy with vaccine primed autologous Tcells for ovarian cancer treatment. Dr. Coukos's research has unveiled the spontaneous antitumor response in ovarian cancer, challenging previous beliefs and expanding its application beyond ovarian to other solid tumors. He also elucidated critical mechanisms governing the interplay between tumors and the immune system, including the role of the tumor vasculature in erecting a barrier to T cell trafficking in tumors. His translational efforts have led to significant clinical advancements, and he continues to lead groundbreaking trials in the field. Dr. Coukos is at the forefront of precision oncology, leveraging advanced technologies like high throughput sequencing to tailor immunotherapies based on molecular and genetic specifics of the tumor cells and the tumor microenvironment. His research pursuits of innovative therapies have set new standards in cancer immunotherapy, including the recent development of rational engineering of superior effector T cell states for adoptive therapy.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
You have truly created something of a “Davos of personalized medicine” conference, which has value beyond ASCO and ASH.
Manish Kohli, MD, Professor and Jack R. and Hazel M. Robertson Presidential Endowed Chair, Huntsman Cancer Institute
PMWC is indeed 'The Davos of Biotech'
Brook Byers, Founding Partner, Kleiner Perkins, Pioneer in Life Sciences & Healthcare Investing
There is no other event with such a lineup of leaders in their field. My annual MUST event since 2013!
Thomas Wilckens, MD, VP Precision Medicine & Precision Health, ECTT
Now THAT is a stellar line up!!
Dawn Cardeiro, MS, Director, Roche
I am thrilled to hear about the impressive lineup of speakers and the engaging topics planned for the conference.
Amanda Acerbi, PharmD, Precision Medicine Global Director, Janssen (J&J)
PMWC is a landmark event, a real tour de force in precision medicine!
Mehme Hachem, PhD, Sr. Bioinformatician, IO / ML, Université de Montréal
Congrats. This is an amazing rock star lineup.
Amanda Cashin, PhD, Bio Company Builder & Investor, Wing VC
The PMWC program and speaker lineup is one of the most impactful and thoughtfully curated conferences in healthcare today.
Tanmay Khilnani, Founder & Chief, Dept. of Medicine, University of Washington
I’ve spoken and had exhibitions in the past at PMWC — one of my favorite conferences of the year — and this lineup is extra impressive.
Tod Klingler, PhD, Co-Founder & CEO, GeneLeap
Tal has done an amazing job developing the PMWC into the #1 premier precision medicine conference.
Trish Brown, SVP, Payer Relations and Reimbursement, GeneDx
Incredible line up! Great event you are putting on
Christina Zigliotto, Head of Generative AI & Machine Learning, Amazon AWS
What an impressive lineup.
I-Chen Fong, PharmD, Ambulatory Care Pharmacist, Kaiser Permanente
Congratulations on the amazing speaker lineup. Wow!
Snehit Prabhu, PhD, Chief Data Scientist, Cancer Cell Therapy, Stanford Cancer Institute
PMWC was excellent, and the lineup sounds truly impressive!
Liat Dassa, PhD, Director of Program Planning, Biology & Computational Models, CytoReason
The line up has come together beautifully and quite impressively. Many people have mentioned how much they are looking forward to it.
Andrea Vuturo, Partner, Vuturo Group
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.